Most lately, it's been identified that conolidine and the above mentioned derivatives act about the atypical chemokine receptor three (ACKR3. Expressed in identical places as classical opioid receptors, it binds into a big selection of endogenous opioids. In contrast to most opioid receptors, this receptor acts being a scavenger and won't activate